SG Americas Securities
CRMD icon

SG Americas Securities’s CorMedix CRMD Stock Holding History

SG Americas Securities’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,182
Closed -$328K – 3324
2025
Q4 		$328K Buy
28,182
+7,849
+39% +$86.8K ﹤0.01% 2711
2025
Q3 		$236K Buy
20,333
+11,858
+140% +$143K ﹤0.01% 2647
2025
Q2 		$104K Sell
8,475
-11,567
-58% -$128K ﹤0.01% 2618
2025
Q1 		$123K Sell
20,042
-7,163
-26% -$74.1K ﹤0.01% 2894
2024
Q4 		$220K Buy
27,205
+8,372
+44% +$83.6K ﹤0.01% 2065
2024
Q3 		$152K Buy
+18,833
New +$102K ﹤0.01% 2720
2024
Q1 		– Sell
-28,465
Closed -$107K – 3046
2023
Q4 		$107K Buy
+28,465
New +$98K ﹤0.01% 2716
2022
Q1 		– Sell
-15,515
Closed -$71K – 3040
2021
Q4 		$71K Sell
15,515
-11,814
-43% -$58.6K ﹤0.01% 3149
2021
Q3 		$127K Buy
+27,329
New +$159K ﹤0.01% 3548
2020
Q3 		– Sell
-14,053
Closed -$89K – 2836
2020
Q2 		$89K Buy
+14,053
New +$65.1K ﹤0.01% 3422

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SG Americas Securities's CRMD Position: Q1 2026 in Review

SG Americas Securities sold out of CorMedix (CRMD) in Q1 2026, closing a stake of 28,182 shares — an estimated $328K sold.

SG Americas Securities first reported a position in CRMD in Q2 2020 and held it in 10 quarters. The position peaked at $328K in Q4 2025. 188 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • SG Americas Securities reported no remaining CorMedix position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 28,182 CorMedix shares in Q1 2026, an estimated $328K.
  • SG Americas Securities first reported a position in CorMedix in Q2 2020 and held it in 10 quarters.
  • SG Americas Securities's CorMedix position peaked at $328K in Q4 2025.
  • 188 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.